Thyrotoxicosis turns up the the CICM past papers about as often as does myxoedema coma, which is probably still more often than it turns up in clinical practice. So far, three notable SAQs have brought up this topic.
Question 25 from the second paper of 2013 asks for some drugs which are used in the management of thyrotoxic crisis. Also, Question 15.1 from the first paper of 2017 presents a case of a patient whose TSH-secreting adenoma was massaged a little too much by the surgeon during the trans-sphenoidal resection, resulting in a post-operative thyroid storm in the recovery room. Lastly, a small 30% component of Question 13 from the second paper of 2018 asked for a list of clinical features of thyroid storm specifically.
A reasonable reference to base one's study notes upon would be Chapter 60 of Oh's Manual, Thyroid emergencies by Jonathan M Handy and Alexander M Man Ying Li (pp. 652). The summary below is based largely on their work. Emphasis was given to the content of the Blue Boxes, as these tend to be mined by the examiners. They are a rich source of lists, and lists are easily made into SAQs ("name six causes of this or that, etc"). Another excellent resource for thyrotoxicosis is Caroll & Matfin (2010); if for whatever reason the exam candidate feels the need to read beyond Oh's, they could safely stop after this article. If one is for some reason unable to safely stop reading, one could carry on to digest the expansive and definitive 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis, which carries on for ninety pages.
- The management strategy for thyroid storm revolves around preventing peripheral effects of raised thyroid hormone levels, and preventing the ongoing increase of said levels by inhibiting the synthesis and release of thyroid hormone.
- The mainstay agents are propylthiouracil, carbimazole (or methimazole), potassium iodide and a beta-blocker such as propanolol.
- One cannot forget to mention corticosteroids, as there is always some relative adrenal insufficiency.
- Other potentially useful agents include lithium and cholestyramine.
- Severe refractory disease may call for extracorporal clearance of thyroid hormone by plasma exchange or charcoal haemoperfusion.
- Prevent synthesis of T3 and T4:
- Thiouracils: propylthiouracil - blocks synthesis of T3 and T4 as well as peripheral T4-T3 conversion
- Imidazoles: carbimazole - block synthesis of T3 and T4
- Prevent T3 and T4 release:
- Inorganic iodine therapy, eg. potassium iodide (given after synthesis is blocked)
- Block peripheral T3 and T4 activity:
- β-blockade: propanolol (which also decreases T4-T3 conversion)
- Corticosteroids: also decrease T4-T3 conversion
Like the electrical storm of ventricular arrhythmias, this has no widely accepted definition. Among review literature, it generally seems to be regarded as not a well-defined clinical entity of its own right, but rather part of the spectrum of hyperthyroidism. Hyperthyroidism becomes thyroid storm when its manifestations become life-threatening, which apparently happens in 1-2% of patients with clinically overt hyperthyroidism (Karger & Führer, 2008). UpToDate describes it as "an exaggeration of the usual symptoms of hyperthyroidism", but avoid giving any real defining features. Chris Nickson from LITFL defined it as a "life threatening exacerbation of hyperthyroid state with 1 or more organ dysfunction" which is as good a definition as any. Back in the 1990s, Birch & Wartofsky (1993) had gone as far as to actually develop a scoring system to define this condition (the table from their article is reproduced somewhere below). In their system, a score in excess of 45 defined thyroid storm. However it is unclear how this definition should be used, considering that treatment for thyrotoxicosis would be offered even to patients who get a low score, and the aggression of therapy would escalate directly in proportion to the severity of the disease.
We can devise a table to classify these precipitants:
An attempt has been made to produce some diagnostic criteria (Burch and Wartofsky, 1993); the authors proposed a scoring system whereby one attributes points to different clinical features.
If one scores over 45, thyroid storm is very likely, and a score of 25-44 suggests that it is imminent.
Thiouracils: propylthiouracil blocks synthesis of T3 and T4 as well as peripheral T4-T3 conversion. In the thyroid gland, propythiouracil blocks the organification of iodide by inhibiting thyroperoxidase, the enzyme responsible for oxidising the iodide anion. Thus, iodide cannot be added to tyrosine residues of thyroglobulin, and thyroid hormone synthesis dies off. It is therefore important to give the patient some propylthiouracil before giving them iodide.
Imidazoles: methimazole or carbimazole (which is metabolised into methimazole) also block synthesis of T3 and T4 by interfering with the action of thyroperoxidase. it has a longer half-life than propylthiouracil.
Imidazoles should probably be the first-line choice in patients who are not critically ill. Nakamura et al (2013) compared the efficacy of methimazol and propylthiouracil in a prospective randomised study of non-storming patients with Graves disease. The authors concluded that even lowish-dose methimazole (15mg/d) is very effective, and that propylthiouracil cannot be recommended as an initial treatment because of poor efficacy and severe side effects.
On the other hand, propylthiouracil is also able to block peripheral T4-T3 conversion. UpToDate (American) authors recommend propylthiouracil over methimazole in thyroid storm because of this factor. There is also some evidence of more rapid action - T3 levels decrease more quickly with propylthiouracil (Cooper et al, 1982). Therefore, propylthiouracil should be the first choice in the ICU setting, particularly in the context of thyroid storm (Lechner & Angell, 2020)
Given that the two drugs compete for the same enzyme, there may be no synergistic effect in giving both at the same time.
Inorganic iodine therapy, eg. potassium iodide (given after synthesis is blocked with propylthiouracil or methimazole) is effective because iodine blocks the release of T4 and T3 from the gland within hours. Also, large doses of iodine can inhibit the organification of iodine, which is called the Wolff-Chaikoff effect (Abrahams, 2005). However, the iodide transport system soon adapts to higher concentrations of iodine, and there may be an "escape" effect where thyroid hormone synthesis starts again. This is why iodide therapy is best combined with a syntheis blocking agent like methimazole.
Lithium has also been used to block the release of thyroid hormone (Bogazzi et al, 2002). Shek et al (2006) also demonstrated satisfactory control of thyrotoxicosis in non-storming patients who had contraindications to propylthiouracil and carbimazole. The authors both complained that the response was slow. The savvy candidate should be aware of this agent for the exams, but its use for thyroid storm is hampered by its pointlessness and by the existence of less toxic agents. One can potentially envision a situation where a patient who is for some reason intolerant of potassium iodide might benefit from lithium instead.
Many drugs block peripheral T4-T3 conversion.
Of these, iodinated contrast agents are probably the most potent. Roti et al (1988) had demonstrated a significant and rapid decrease in circulating T3 levels with sodium ipodate, which normally goes by the name Oragrafin. Apparently, yuou can also use ipanoic acid (Telepaque). Standard Gastrografin (sodium amidotrizoate) will not cut it.
Of course, this arm of the therapy is not a very effective pathway, as it only works on the small pool of potentially harmful T4. Treatments which prevent the synthesis of T4 and block its release are probably more effective in the long run, and in the short term more good will be done by focusing on blocking the peripheral effects of thyroid hormone.
β-blockade with propanolol (which also decreases T4-T3 conversion) is the standard of acute care. Most of the immediately life-threatening consequences of thyoroid storm are cardiovascular. Propanolol is effective in controlling heart rate; with a slower rate the cardiac failure may actually improve and the blood pressure may paradoxically increase. The alternative agent is the easily titratable esmolol, but you miss out on the peripheral T4-T3 conversion blockade.
Corticosteroids are routinely used in thyroid storm to address the coexisting hypoadrenal state. Their peripheral effects on T4-T3 conversion are trivial and probably have little influence on their effectiveness in thyrotoxicosis. Thyroid disease (particularly long-standing hyperthyroidism) is associated with a diminished adrenal reserve (Tsatsoulis et al, 2000) and the addition of a small amount of hydrocortisone seems to correct this. An additional benefit is the treatment of whatever autoimmune disease is responsible (Graves, Hashimoto, etc)
Cholestyramine is a bile acid sequestrant which prevents the reabsorption of thyroid hormone which is excreted with the bile. The normal metabolism of T3 involves conjugation with glucuronide and sulfate, and the excretion of this product in the bile. Free thyroid hormones are released in the intestine and are then reabsorbed. This recirculation makes the gut a potentially massive reservoir of thyroid hormones. The addition of cholestyramine to other medical management strategies tends to decrease the levels of circulating T3 and T4 (Solomon et al, 1993). The key is not to administer it together with other medications (it may bind them and reduce their efficacy).
Plasma exchange is an effective treatment for this problem, and is one of the effective last resort measures in severe thyroid storm with multiorgan system failure. Experience with it is based on case series only, albeit encouraging ones. Binimelis et al (1987) reported that the rate of T4 clearance was about thirty times higher than with standard medical management (that was a case series of six patients with massive thyroxine overdose).
Haemoperfusion is even better than plasma exchange. Binimelis et al (1987) reported that with charcoal haemoperfusion the clearance rate for T3 was even higher than with plasmapheresis. This technique has been known about since the ancient times (Herrmann et al, 1977), but more recently there has ben a resurgence in interest with the development of safer filters. Kreisner et al (2010) report a more recent case. Three 2-hour sessions were required.
This seems drastic, but it may be the only choice in patients who have failed medical therapy. Weber et al (1999) presents such a case series, where all medically refractory patients underwent subtotal thyroidectomy and did well therafter.
Migneco, A., et al. "Management of thyrotoxic crisis." Congestive heart failure140 (2005): 25.
Lechner, Melissa G., and Trevor E. Angell. "Severe Thyrotoxicosis and Thyroid Storm." Handbook of Inpatient Endocrinology. Springer, Cham, 2020. 33-42.
Burch, Henry B., and L. Wartofsky. "Life-threatening thyrotoxicosis. Thyroid storm." Endocrinology and metabolism clinics of North America 22.2 (1993): 263-277.
Chiha, Maguy, Shanika Samarasinghe, and Adam S. Kabaker. "Thyroid Storm An Updated Review." Journal of intensive care medicine 2015;30:131–40
Binimelis, J., et al. "Massive thyroxine intoxication: evaluation of plasma extraction." Intensive care medicine 13.1 (1987): 33-38.
Herrmann, J., et al. "Charcoal haemoperfusion in thyroid storm." The Lancet 309.8005 (1977): 248.
Kreisner, Edmundo, Mauricio Lutzky, and Jorge L. Gross. "Charcoal hemoperfusion in the treatment of levothyroxine intoxication." Thyroid 20.2 (2010): 209-212.
Wald, David A., and Allison Silver. "Cardiovascular manifestations of thyroid storm: a case report." The Journal of emergency medicine 25.1 (2003): 23-28.
Nakamura, Hirotoshi, et al. "Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves’ disease." The Journal of Clinical Endocrinology & Metabolism (2013).
COOPER, DAVID S., et al. "Acute Effects of Propylthiouracil (PTU) on Thyroidal Iodide Organification and Peripheral Iodothyronine Deiodination: Correlation with Serum PTU Levels Measured by Radioimmunoassay*." The Journal of Clinical Endocrinology & Metabolism 54.1 (1982): 101-107.
Abraham, Guy E. "The Wolff-Chaikoff Effect: Crying Wolf." The Original Internist 12.3 (2005): 112-118.
Roti, E., et al. "COMPARISON OF METHIMAZOLE, METHIMAZOLE AND SODIUM IPODATE, AND METHIMAZOLE AND SATURATED SOLUTION OF POTASSIUM IODIDE IN THE EARLY TREATMENT OF HYPERTHYROID GRAVES’DISEASE." Clinical endocrinology 28.3 (1988): 305-314.
Tsatsoulis, A., et al. "The effect of thyrotoxicosis on adrenocortical reserve." European journal of endocrinology 142.3 (2000): 231-235.
Solomon, Barbara L., Leonard Wartofsky, and Kenneth D. Burman. "Adjunctive cholestyramine therapy for thyrotoxicosis*." Clinical endocrinology 38.1 (1993): 39-43.
Bogazzi, Fausto, et al. "Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves’ disease." The Journal of Clinical Endocrinology & Metabolism 87.10 (2002): 4490-4495.
Shek, C. C., and 石志忠. "Use of lithium in the treatment of thyrotoxicosis." Hong Kong Med J 12.4 (2006): 254-9.
Weber, C., et al. "Thyroidectomy in iodine induced thyrotoxic storm." Experimental and clinical endocrinology & diabetes: official journal, German Society of Endocrinology [and] German Diabetes Association 107.7 (1998): 468-472.
Karger, S., and D. Führer. "Thyreotoxische Krise-ein Update." DMW-Deutsche Medizinische Wochenschrift 133.10 (2008): 479-484.
Carroll, Richard, and Glenn Matfin. "Endocrine and metabolic emergencies: thyroid storm." Therapeutic advances in endocrinology and metabolism 1.3 (2010): 139-145.
Ross, Douglas S., et al. "2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis." Thyroid 26.10 (2016): 1343-1421.